• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对有和没有基于知识的剂量预测的妇科癌症患者进行每日自适应放疗的剂量学获益建模。

Modeling dosimetric benefits from daily adaptive RT for gynecological cancer patients with and without knowledge-based dose prediction.

作者信息

Ghimire Rupesh, Moore Lance, Branco Daniela, Rash Dominique L, Mayadev Jyoti S, Ray Xenia

机构信息

Department of Radiation Medicine and Applied Sciences, UC San Diego Health, La Jolla, California, USA.

出版信息

J Appl Clin Med Phys. 2025 Mar;26(3):e14596. doi: 10.1002/acm2.14596. Epub 2025 Jan 27.

DOI:10.1002/acm2.14596
PMID:39868634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11905257/
Abstract

PURPOSE

Daily online adaptive radiotherapy (ART) improves dose metrics for gynecological cancer patients, but the on-treatment process is resource-intensive requiring longer appointments and additional time from the entire adaptive team. To optimize resource allocation, we propose a model to identify high-priority patients.

METHODS

For 49 retrospective cervical and endometrial cancer patients, we calculated two initial plans: the treated standard-of-care (Initial) and a reduced margin initial plan (Initial) for adapting with the Ethos treatment planning system. Daily doses corresponding to standard and reduced margins (Daily and Daily) were determined by re-segmenting the anatomy based on the treatment CBCT and calculating dose on a synthetic CT. These initial and daily doses were used to estimate the ART benefit ( = Daily-Daily) versus initial plan differences ( = Initial-Initial) via multivariate linear regression. Dosimetric benefits were modeled with initial plan differences ( ) of (cc), (Gy), and (Gy). Anatomy (intact uterus or post-hysterectomy), DoseType (simultaneous integrated boost [SIB] vs. single dose), and/or prescription value. To establish a logistic model, we classified the top 10% in each metric as high-benefit patients. We then built a logistic model to predict these patients from the previous predictors. Leave-one-out validation and ROC analysis were used to evaluate the accuracy. To improve the clinical efficiency of this predictive process, we also created knowledge-based plans for the ΔInitial plans ( ) and repeated the analysis.

RESULTS

In both and our multivariate analysis showed low R values 0.34-0.52 versus 0.14-0.38. The most significant predictor in each multivariate model was the corresponding ∆Initial metric (e.g., Bowel (V40 Gy), p < 1e-05). In the logistic model, the metrics with the strongest correlation to the high-benefit patients were (cc), (Gy), , and prescription. The models for original and knowledge-based plans had an AUC of 0.85 versus 0.78. The sensitivity and specificity were 0.92/0.72 and 0.69/0.80, respectively.

CONCLUSION

This methodology will allow clinics to prioritize patients for resource-intensive daily online ART.

摘要

目的

每日在线自适应放疗(ART)可改善妇科癌症患者的剂量指标,但治疗过程资源密集,需要更长的预约时间以及整个自适应团队投入额外时间。为了优化资源分配,我们提出了一种识别高优先级患者的模型。

方法

对于49例回顾性宫颈癌和子宫内膜癌患者,我们计算了两个初始计划:采用Ethos治疗计划系统进行适配的已治疗的标准治疗方案(初始方案)和缩小 margins 的初始计划(初始方案)。基于治疗CBCT对解剖结构进行重新分割,并在合成CT上计算剂量,从而确定对应标准 margins 和缩小 margins 的每日剂量(每日剂量和每日剂量)。通过多元线性回归,利用这些初始剂量和每日剂量来估计ART获益(=每日剂量 - 每日剂量)与初始计划差异(=初始方案 - 初始方案)。剂量学获益通过初始计划差异()为(cc)、(Gy)和(Gy)进行建模。解剖结构(完整子宫或子宫切除术后)、剂量类型(同步整合加量 [SIB] 与单次剂量)和/或处方值。为建立逻辑模型,我们将每个指标中排名前10%的患者归类为高获益患者。然后,我们构建了一个逻辑模型,根据先前的预测指标来预测这些患者。采用留一法验证和ROC分析来评估准确性。为提高这种预测过程的临床效率,我们还为Δ初始计划()创建了基于知识的计划,并重复了分析。

结果

在和中,我们的多变量分析显示R值较低,分别为0.34 - 0.52和0.14 - 0.38。每个多变量模型中最显著的预测指标是相应的∆初始指标(例如,肠(V40 Gy),p < 1e - 05)。在逻辑模型中,与高获益患者相关性最强的指标是(cc)、(Gy)、和处方。原始计划和基于知识的计划的模型AUC分别为0.85和0.78。敏感性和特异性分别为0.92/0.72和0.69/0.80。

结论

这种方法将使临床能够对资源密集型的每日在线ART患者进行优先级排序。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/bb37d438e7c9/ACM2-26-e14596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/cb69a4c16925/ACM2-26-e14596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/27519ab5d94f/ACM2-26-e14596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/1fc4218ba9dd/ACM2-26-e14596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/dd210b923358/ACM2-26-e14596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/c36de46137df/ACM2-26-e14596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/ce1a2d128a89/ACM2-26-e14596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/bb37d438e7c9/ACM2-26-e14596-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/cb69a4c16925/ACM2-26-e14596-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/27519ab5d94f/ACM2-26-e14596-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/1fc4218ba9dd/ACM2-26-e14596-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/dd210b923358/ACM2-26-e14596-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/c36de46137df/ACM2-26-e14596-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/ce1a2d128a89/ACM2-26-e14596-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce85/11905257/bb37d438e7c9/ACM2-26-e14596-g001.jpg

相似文献

1
Modeling dosimetric benefits from daily adaptive RT for gynecological cancer patients with and without knowledge-based dose prediction.对有和没有基于知识的剂量预测的妇科癌症患者进行每日自适应放疗的剂量学获益建模。
J Appl Clin Med Phys. 2025 Mar;26(3):e14596. doi: 10.1002/acm2.14596. Epub 2025 Jan 27.
2
Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer.预测宫颈癌患者从每日在线自适应放疗中获得的个体化剂量学获益。
Biomed Phys Eng Express. 2023 Jun 30;9(4). doi: 10.1088/2057-1976/acdf62.
3
Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.头颈部癌症中通过概率治疗计划将患者几何变化纳入自适应计划优化的剂量学评估。
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):985-997. doi: 10.1016/j.ijrobp.2018.03.062. Epub 2018 Apr 5.
4
Dosimetric and feasibility evaluation of a CBCT-based daily adaptive radiotherapy protocol for locally advanced cervical cancer.基于锥形束 CT 的局部晚期宫颈癌每日自适应放疗计划的剂量学和可行性评估。
J Appl Clin Med Phys. 2023 Jan;24(1):e13783. doi: 10.1002/acm2.13783. Epub 2022 Oct 8.
5
Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear.宫颈癌每日在线自适应放疗的剂量学改善:跳着旋转木马舞。
Clin Oncol (R Coll Radiol). 2024 Mar;36(3):165-172. doi: 10.1016/j.clon.2024.01.005. Epub 2024 Jan 17.
6
Automated daily dose accumulation workflow for treatment quality assurance during online adaptive radiotherapy with a 0.35T MR-linac.在使用0.35T磁共振直线加速器进行在线自适应放疗期间,用于治疗质量保证的每日剂量自动累积工作流程。
J Appl Clin Med Phys. 2025 Mar;26(3):e14594. doi: 10.1002/acm2.14594. Epub 2024 Dec 20.
7
The clinical practice and dosimetric outcome of the manual adaptive planning during definitive radiotherapy for cervical cancer.宫颈癌根治性放疗中手动自适应计划的临床实践和剂量学结果。
J Cancer Res Clin Oncol. 2024 May 27;150(5):280. doi: 10.1007/s00432-024-05809-z.
8
Impact of the gradient in gantry-table rotation on dynamic trajectory radiotherapy plan quality.机架-治疗床旋转梯度对动态轨迹放射治疗计划质量的影响。
Med Phys. 2023 Nov;50(11):7104-7117. doi: 10.1002/mp.16749. Epub 2023 Sep 25.
9
Dose tracking assessment for magnetic resonance guided adaptive radiotherapy of rectal cancers.磁共振引导自适应放疗直肠癌的剂量跟踪评估。
Radiat Oncol. 2024 Sep 2;19(1):114. doi: 10.1186/s13014-024-02508-4.
10
Clinical Implementation of "Plan of the Day" Strategy in Definitive Radiation Therapy of Cervical Cancer: Online Adaptation to Address the Challenge of Organ Filling Reproducibility.宫颈癌根治性放疗中“今日计划”策略的临床实施:在线适应以应对器官充盈可重复性挑战
Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):605-615. doi: 10.1016/j.ijrobp.2023.09.045. Epub 2023 Oct 9.

本文引用的文献

1
Daily Online Adaptive Radiation Therapy of Postoperative Endometrial and Cervical Cancer With PTV Margin Reduction to 5 mm: Dosimetric Outcomes, Acute Toxicity, and First Clinical Experience.术后子宫内膜癌和宫颈癌的每日在线自适应放射治疗,将计划靶区边缘缩小至5毫米:剂量学结果、急性毒性及首次临床经验
Adv Radiat Oncol. 2024 Apr 13;9(7):101510. doi: 10.1016/j.adro.2024.101510. eCollection 2024 Jul.
2
Unlocking the adaptive advantage: correlation and machine learning classification to identify optimal online adaptive stereotactic partial breast candidates.解锁适应性优势:相关性和机器学习分类以确定最佳在线自适应立体定向部分乳房候选者。
Phys Med Biol. 2024 May 30;69(11). doi: 10.1088/1361-6560/ad4a1c.
3
Adaptive Radiotherapy: Next-Generation Radiotherapy.
自适应放疗:下一代放疗技术
Cancers (Basel). 2024 Mar 19;16(6):1206. doi: 10.3390/cancers16061206.
4
Intrafraction Motion and Margin Assessment for Ethos Online Adaptive Radiotherapy Treatments of the Prostate and Seminal Vesicles.前列腺和精囊的Ethos在线自适应放射治疗中的分次内运动和边界评估
Adv Radiat Oncol. 2023 Nov 4;9(3):101405. doi: 10.1016/j.adro.2023.101405. eCollection 2024 Mar.
5
Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear.宫颈癌每日在线自适应放疗的剂量学改善:跳着旋转木马舞。
Clin Oncol (R Coll Radiol). 2024 Mar;36(3):165-172. doi: 10.1016/j.clon.2024.01.005. Epub 2024 Jan 17.
6
Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study.评估每日迭代在线自适应放疗在子宫内膜癌和宫颈癌术后治疗中的应用:一项前瞻性单臂 2 期研究。
Radiat Oncol. 2024 Jan 4;19(1):2. doi: 10.1186/s13014-023-02394-2.
7
Stereotactic MR-guided on-table adaptive radiation therapy (SMART) for borderline resectable and locally advanced pancreatic cancer: A multi-center, open-label phase 2 study.立体定向磁共振引导下术中自适应放疗(SMART)治疗局部进展期和局部可切除胰腺癌的多中心、开放标签Ⅱ期研究。
Radiother Oncol. 2024 Feb;191:110064. doi: 10.1016/j.radonc.2023.110064. Epub 2023 Dec 20.
8
Adaptive Radiation Therapy: A Review of CT-based Techniques.自适应放疗:基于 CT 的技术综述。
Radiol Imaging Cancer. 2023 Jul;5(4):e230011. doi: 10.1148/rycan.230011.
9
Forecasting patient-specific dosimetric benefit from daily online adaptive radiotherapy for cervical cancer.预测宫颈癌患者从每日在线自适应放疗中获得的个体化剂量学获益。
Biomed Phys Eng Express. 2023 Jun 30;9(4). doi: 10.1088/2057-1976/acdf62.
10
Online Adaptive Radiation Therapy and Opportunity Cost.在线自适应放射治疗与机会成本。
Adv Radiat Oncol. 2022 Oct 26;8(3):101034. doi: 10.1016/j.adro.2022.101034. eCollection 2023 May-Jun.